arrow
M

Mats Remberger

Uppsala University Hospital
H指数:61
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Herpes zoster frequency and adjuvanted recombinant zoster vaccination after allogeneic hematopoietic cell transplantation

带状疱疹频率及异基因造血细胞移植后的佐剂重组带状疱疹疫苗接种

2025-10-280
PRE
Don´t Fly and Freeze: Impact of Ex Vivo Time, Cell Density and Cryopreservation on Allogeneic Stem Cell Grafts

不要飞行和冷冻:异体干细胞移植中离体时间、细胞密度和冷冻保存的影响

2025-09-190
PRE
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis

能否超越骨髓清除性预处理(MAC)?一项在年龄小于65岁的异基因造血细胞移植患者中使用ATG-PTCy-CSA预防GVHD的MAC与减低强度预处理(RIC)的比较研究

2025-09-180
PRE
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation

异基因造血干细胞移植后,移植物抗宿主病预防措施对第二原发恶性肿瘤的影响

2025-07-190
PRE
Effect of Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide on GvHD Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia

抗胸腺细胞球蛋白和移植后环磷酰胺对女性供者至男性受者配型无关供者异基因造血干细胞移植治疗急性白血病中GVHD预后的影响

2025-07-130
PRE
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant With Graft Failure and Relapse Risk in Hematological Malignancies

异基因造血细胞移植后环孢素暴露与血液系统恶性肿瘤中移植物失败和复发风险的关系

2025-06-110
PRE
Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

在AML患者中,对于65岁以下人群,采用抗胸腺细胞球蛋白与移植后环磷酰胺联合作为GVHD预防措施时,可改善预后。

BLOOD
IF23.1
2024-11-050
PRE
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome

异基因造血干细胞移植中年龄较大的同胞供者和年龄较小的无缘供者的选择: 急性髓系白血病和骨髓增生异常综合征临床结果的比较

2023-11-018
OAAI
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
2023-10-302
OAAI
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation

大剂量静脉白消安与移植后环磷酰胺对异基因造血干细胞移植后出血性膀胱炎的相互作用

2023-09-012
OAAI
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience

改善异基因造血干细胞移植后的安全性和结局: 单中心经验

2022-05-016
OAAI
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study

异基因造血干细胞移植后血流感染与预后: 一项单中心研究

2022-01-0123
OAAI